一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Pharmaceuticals >>article
Pharmaceuticals

Pharmaceuticals

IF: 4.3
Download PDF

Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application.

Published:9 September 2024 DOI: 10.3390/ph17091186 PMID: 39338348
Tatiana A Fedotcheva,?Maria E Uspenskaya,?Darya N Ulchenko,?Nikolay L Shimanovsky

Abstract

Dehydroepiandrosterone and its sulfate are the most abundant steroids in humans. The metabolism of dehydroepiandrosterone can differ significantly depending on the organ or tissue and the subtype of steroid receptors expressed in it. For dehydroepiandrosterone, as a precursor of all steroid hormones, intracrine hormonal activity is inherent. This unique feature could be beneficial for the medicinal application, especially for the local treatment of various pathologies. At present, the clinical use of dehydroepiandrosterone is limited by its Intrarosa? (Quebec city, QC, Canada) prasterone) 6.5 mg vaginal suppositories for the treatment of vaginal atrophy and dyspareunia, while the dehydroepiandrosterone synthetic derivatives Triplex, BNN 27, and Fluasterone have the investigational status for the treatment of various diseases. Here, we discuss the molecular targets of dehydroepiandrosterone, which open future prospects to expand its indications for use. Dehydroepiandrosterone, as an oral drug, is surmised to have promise in the treatment of osteoporosis, cachexia, and sarcopenia, as does 10% unguent for skin and muscle regeneration. Also, 5-androstenediol, a metabolite of dehydroepiandrosterone, is a promising candidate for the treatment of acute radiation syndrome and as an immunostimulating agent during radiopharmaceutical therapy. The design and synthesis of new 5-androstenediol derivatives with increased bioavailability may lead to the appearance of highly effective cytoprotectors on the pharmaceutical market. The argumentations for new clinical applications of these steroids and novel insights into their mechanisms of action are discussed.

Substances (5)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Dehydroepiandrosterone 53-43-0 C19H28O2 692 suppliers $18.00-$2760.00
5-ANDROSTENEDIOL 25975-59-1 C18H28O2 26 suppliers Inquiry
Fluasterone 112859-71-9 C19H27FO 17 suppliers Inquiry
ApoTox-Glo Triplex Assay 12 suppliers Inquiry
Scattered blue BNN 3 suppliers Inquiry

Similar articles

IF:40.8

Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.

Signal Transduction and Targeted Therapy Bei Wang,?Lujin Wu,etc Published: 26 February 2021
IF:72.5

5-Fluorouracil: mechanisms of action and clinical strategies

Nature Reviews Cancer Daniel B. Longley, D. Paul Harkin,etc Published: 1 May 2003
IF:13

Dehydroepiandrosterone (DHEA): hypes and hopes.

Drugs Krzysztof Rutkowski, Pawe? Sowa,etc Published: 1 July 2014
旺苍县| 阳泉市| 洛浦县| 石楼县| 榕江县| 平利县| 浪卡子县| 池州市| 和顺县| 安溪县| 孝义市| 皮山县| 黄浦区| 桑日县| 桐柏县| 洛浦县| 浮梁县| 洛扎县| 武宣县| 建瓯市| 巴中市| 平安县| 长治市| 平潭县| 南丹县| 浦县| 剑川县| 准格尔旗| 建德市| 通化县| 阜平县| 自治县| 东兰县| 南乐县| 鄂托克旗| 山西省| 镇康县| 金门县| 屯门区| 连城县| 六盘水市|